Compounds > levodopa
Page last updated: 2024-08-17

levodopa and Granulocytic Leukemia, Chronic

levodopa has been researched along with Granulocytic Leukemia, Chronic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alacacioglu, I; Bilgir, F; Bilgir, O; Binicier, O; Calan, M; Kebapcilar, L; Oner, P; Payzin, B; Sari, I1
Kaku, DA; Sarasombath, P; Sumida, K1

Other Studies

2 other study(ies) available for levodopa and Granulocytic Leukemia, Chronic

ArticleYear
Does imatinib mesylate therapy cause growth hormone deficiency?
    Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2009, Volume: 18, Issue:5

    Topics: Adult; Benzamides; Female; Glucagon; Human Growth Hormone; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Levodopa; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pyrimidines

2009
Parkinsonism associated with interferon alpha therapy for chronic myelogenous leukemia.
    Hawaii medical journal, 2002, Volume: 61, Issue:3

    Topics: Aged; Antineoplastic Agents; Antiparkinson Agents; Carbidopa; Humans; Interferon alpha-2; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Levodopa; Male; Parkinson Disease, Secondary; Recombinant Proteins; Treatment Outcome

2002